Get the Stockscreener App
85.37
1.81%
-1.57
Healthequity Inc stock is traded at $85.37, with a volume of 1.08M.
It is down -1.81% in the last 24 hours and down -11.07% over the past month.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
See More
Previous Close:
$86.94
Open:
$86.49
24h Volume:
1.08M
Relative Volume:
1.19
Market Cap:
$7.29B
Revenue:
$1.15B
Net Income/Loss:
$96.70M
P/E Ratio:
78.32
EPS:
1.09
Net Cash Flow:
$-161.99M
1W Performance:
-9.33%
1M Performance:
-11.07%
6M Performance:
-12.59%
1Y Performance:
-14.71%
1-Day Range:
$85.21
$88.04
1-Week Range:
$82.74
$91.33
52-Week Range:
$74.07
$116.65
Healthequity Inc Stock (HQY) Company Profile
Name
Healthequity Inc
Sector
Industry
Phone
801-727-1000
Address
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HQY
Healthequity Inc
|
85.37 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
VEEV
Veeva Systems Inc
|
222.21 | 35.99B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
70.33 | 12.26B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
41.26 | 7.73B | 550.17M | 201.35M | 232.07M | 1.00 |
|
BTSG
Brightspring Health Services Inc
|
39.20 | 7.14B | 11.99B | 24.18M | 234.31M | 0.2956 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Downgrade | Goldman | Neutral → Sell |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| May-22-25 | Resumed | RBC Capital Mkts | Outperform |
| Mar-25-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Apr-02-24 | Reiterated | JP Morgan | Overweight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-21-22 | Upgrade | Goldman | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-12-22 | Initiated | Goldman | Sell |
| Apr-11-22 | Initiated | Wells Fargo | Overweight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Mar-30-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-07-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Sep-09-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Jul-02-21 | Initiated | Stephens | Overweight |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Jan-07-21 | Initiated | BTIG Research | Neutral |
| Dec-08-20 | Reiterated | Barrington Research | Outperform |
| Dec-02-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-14-20 | Initiated | Guggenheim | Buy |
| Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
| Mar-17-20 | Reiterated | Barrington Research | Outperform |
| Oct-07-19 | Initiated | Goldman | Neutral |
| Sep-09-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jul-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-05-19 | Reiterated | BofA/Merrill | Neutral |
| Mar-01-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-07-19 | Reiterated | Chardan Capital Markets | Buy |
| Feb-07-19 | Upgrade | SunTrust | Hold → Buy |
| Dec-06-18 | Downgrade | SunTrust | Buy → Hold |
| Sep-06-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| May-23-18 | Initiated | BofA/Merrill | Buy |
| Apr-24-18 | Resumed | JP Morgan | Overweight |
| Mar-20-18 | Reiterated | Chardan Capital Markets | Buy |
| Dec-06-17 | Reiterated | Chardan Capital Markets | Buy |
View All
Healthequity Inc Stock (HQY) Latest News
Stephens Investment Management Group LLC Has $68.64 Million Stock Holdings in HealthEquity, Inc. $HQY - MarketBeat
New York Gov. Hochul Reveals Cannabis Initiatives Aimed at Supply Chain, Health Equity - Cannabis Equipment News
HealthEquity, Inc. (NASDAQ:HQY) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
The Market's Not Diagnosing HealthEquity Accurately (NASDAQ:HQY) - Seeking Alpha
HQYHealthEquity Announces Closing of Follow-on Offering - ADVFN
A Look At HealthEquity (HQY) Valuation As New Guidance And Split Analyst Calls Draw Attention - Sahm
HealthEquity Announces Year-End Sales Outlook, Presentation at JP Morgan Healthcare Conference - ADVFN
HealthEquity (NASDAQ:HQY) Trading Down 6.5%Here's Why - MarketBeat
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2027 - marketscreener.com
HealthEquity expects FY 2027 revenue between $1.38B and $1.41B; shares down over 7% - MSN
HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test - TechStock²
HealthEquity drops after 2027 outlook misses estimates - TradingView — Track All Markets
Why Is HealthEquity’s Hot Streak Suddenly Faltering? - TipRanks
HealthEquity sees FY27 revenue $1.38B-$1.41B, consensus $1.41B - TipRanks
HealthEquity Expects Fiscal 2027 Revenue of $1.38 Billion to $1.41 Billion - marketscreener.com
HealthEquity Issues Confident Fiscal 2027 Outlook and Guidance - TipRanks
HealthEquity, Inc. Projects Fiscal Year 2027 Revenue Range and Reaffirms Fiscal Year 2026 Guidance - Quiver Quantitative
HealthEquity Announces Fiscal Year 2027 Outlook Presentation at J.P. Morgan Healthcare Conference - The Manila Times
Healthequity announces fiscal year 2027 outlook presentation at J.P. Morgan healthcare conference - marketscreener.com
Healthequity Announces Fiscal Year 2027 Outlook Presentation At J.P. Morgan Healthcare Conference - TradingView — Track All Markets
Summit Creek Advisors LLC Sells 15,670 Shares of HealthEquity, Inc. $HQY - MarketBeat
Habilitative Systems, Inc. Honors Education Leaders at 5th Annual Race & Health Equity Awards - 24-7 Press Release Newswire
(HQY) and the Role of Price-Sensitive Allocations - Stock Traders Daily
HealthEquity (NASDAQ:HQY) delivers shareholders decent 16% CAGR over 3 years, surging 3.4% in the last week alone - Yahoo Finance
HealthEquity (NASDAQ:HQY) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Did Goldman's HQY Downgrade Amid Bullish Peers Just Reframe HealthEquity's Valuation Debate? - Sahm
Reasons to Add HealthEquity Stock to Your Portfolio for Now - MSN
HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March - TechStock²
HealthEquity (NASDAQ:HQY) Shares Gap DownShould You Sell? - MarketBeat
Why Healthequity’s Stock Is Struggling Despite Strong Results - TipRanks
Goldman Sachs Downgrades HealthEquity (HQY) to 'Sell' | HQY Stoc - GuruFocus
What 8 Analyst Ratings Have To Say About HealthEquity - Benzinga
Goldman Sachs Downgrades HealthEquity to Sell From Neutral, Adjusts Price Target to $89 From $113 - marketscreener.com
HealthEquity downgraded to Sell from Neutral at Goldman Sachs - TipRanks
Will HealthEquity Inc. stock keep outperforming rivalsMarket Activity Report & Technical Confirmation Alerts - ulpravda.ru
HealthEquity (HQY): Keybanc Raises Price Target to $125.00 | HQY Stock News - GuruFocus
HealthEquity price target raised to $125 from $120 at KeyBanc - TipRanks
Healthequity (HQY) Gets a Buy from J.P. Morgan - The Globe and Mail
Can HealthEquity Inc. stock surprise with earnings upsideResistance Breakout Alerts & Explosive Growth Trading - ulpravda.ru
MarketsMedicine Hat NewsMedicine Hat NewsHealthEquity, Inc.Common Stock (Nasdaq:HQY) Price Chart - FinancialContent
Will HealthEquity Inc. stock recover faster than peers2026 world cup usa national team group stage defensive leaders transition play winner prediction analysis - Улправда
Is HealthEquity Inc 2HE a good long term investmentDividend Stability Analysis & Stocks With 200% Upside Potential - earlytimes.in
Investors Interested In HealthEquity, Inc.'s (NASDAQ:HQY) Earnings - 富途牛牛
Gear Up for HealthEquity (HQY) Q4 Earnings: Wall Street Estimates for Key Metrics - MSN
HealthEquity (FRA:2HE) EV-to-OCF : 20.00 (As of Jan. 03, 2026) - GuruFocus
HealthEquity (NASDAQ:HQY) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Tectonic Advisors LLC Grows Stake in HealthEquity, Inc. $HQY - MarketBeat
Pacer Advisors Inc. Purchases Shares of 11,490 HealthEquity, Inc. $HQY - MarketBeat
Econ Financial Services Corp Makes New Investment in HealthEquity, Inc. $HQY - MarketBeat
HealthEquity, Inc. $HQY Position Cut by Moody Aldrich Partners LLC - MarketBeat
Novavest Real Estate AG AI6 Stock Analysis and ForecastDay Trading Setups & Fast Growing Capital Gains - earlytimes.in
Healthequity Inc Stock (HQY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.01%
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):